The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Disparities in African-American patient enrollment in pivotal phase 3 immunotherapy trials that led to FDA drug approval in patients with non-small cell lung cancer.
 
Chimezie Ubbaonu
No Relationships to Disclose
 
Sai-Hong Ignatius Ou
Stock and Other Ownership Interests - Elevation Oncology; Turning Point Therapeutics
Honoraria - Anheart Therapeutics; BeiGene; DAVA Oncology LLP; JNJ Janssen; Lilly; Pfizer
Consulting or Advisory Role - BeiGene; JNJ/Janssen; Lilly; Pfizer
Speakers' Bureau - JNJ/Janssen; Pfizer
Research Funding - Blueprint Medicines (Inst); Daiichi Sankyo (Inst); Johnson & Johnson/Janssen (Inst); Lilly (Inst); Merus (Inst); Mirati Therapeutics (Inst); Nuvalent, Inc. (Inst); Pfizer (Inst); Revolution Medicines (Inst)